Thursday 22 August 2019  Persian         Arabic
Sina Specialized and subspecialty Hospital

Mojtaba Mojtahedzadeh

Current Rank/Department: Director of Pharmaceutical Care Division

Tehran University of Medical Sciences / Sina Hospital




   

 

Contact Information:

 
Academic Rank:  Full Professor

Department: Clinical Pharmacy – Critical Care Medicine

Address: School of Pharmacy – Department of Clinical Pharmacy

Tel: (+9821) 2287 3871

Tel (Office): (+9821) 6695 9090

Fax: (+9821) 6646 1178

E-mail: Mojtahed@tums.ac.ir

 

Education:
 

July 1994                    Fellowship in Critical Care – Clinical Pharmacy

                                     Texas Southern University

                                   The Methodist Hospital

                                      Houston , Texas 77004

July 1992                     Specialized Residency in Critical Care Medicine

                                    The Methodist Hospital

                                   Baylor College of Medicine

                                      Houston , Texas 77030

May 1991                     PhD / Doctorate Degree in Pharmacy

                                     College of Pharmacy and Health Sciences

                                     Texas Southern University

                                    Houston , Texas 77004

December 1989          Bachelor of Science in Pharmacy

                                     College of Pharmacy and Allied Health Sciences

                                     Northeast Louisiana University

                                    Monroe , Louisiana 71209

 

Highlighted Educational/Professional Qualifications:

 

July 1993      Specialized Residency; Fellowship – Clinical Pharmacy/Critical Care Med

 

Invention        Intragastric Ph probe catheter (approved and registered at the Ministry of Health and  Ministry of Higher Education)

 

Professional Society Membership:

 

1990 – 1996                American Society of Health System Pharmacists

                                    Houston – Galaveston Areas

1990 – 1996                Society of Hospital Pharmacists

1994 – 1995                American Society of University Professors

1992 – 1998                Society of Critical Care Medicine

 

Work Experience:

 

Executive Activities

 

July 2008 - to date

Head of pharmaceutical care division at Sina Hospital Tehran University of Health Sciences _ Tehran Iran

 

Job Description

As the Head of Pharmaceutical care division, I am responsible for leading and development of learning, teaching and research for undergraduate and postgraduate courses as well as management of academic and teacher practitioner staff. I am currently introducing public health as an optional module for pharmacy and other health care professionals.

 

March 2008 - to date

Head of pharmacy and therapeutic committee at Sina Hospital

 

Job Description

I served as a P&T member  since 1999, where the decision on hospital formulary was made based on the evaluated paper. I lead on P&T since July 2008, during which I designed and managed several multidisciplinary clinical trials and DUE projects in partnership with pharmaceutical industry. I have been in charge for appraising the news drugs and assessing their financial implication in the primary acute care.

I am working closely with commissioners in assessing cost-effectiveness of medical procedure and drug therapies offered by hospitals.

 

2004 – Present

 

Professor of Pharmacotherapy and Critical Care Med

Sina Hospital , Tehran University of Medical Sciences

Tehran – Iran

 

2000 – Present

Coordinator of Research in Critical Care Medicine Fellowship Program

Sina Hospital , Tehran University of Medical Sciences

Tehran – Iran

 

2006 – 2008

Secretary of National Drug and Therapy Selection Committee and General Director of Rational Drug Utilization and Evaluation 

Ministry of Health, Treatment and Medical Education

Tehran – Iran

 

1997 – 2000

Chairman Department of Clinical Pharmacy

Tehran University of Medical Sciences

Tehran – Iran

School of Pharmacy

 

  1997 – 1999

Coordinator of Advance Cardiac Life Support Training Program

Tehran University of Medical Sciences

Tehran – Iran

 

1993 – 1995

·        Pharmacy and Therapeutics Committee, Maimonides Medical Center

·        Critical Care Medicine Committee, Maimonides Medical Center

·        Investigational Review Board for Human and Animal Subjects, Maimonides Medical Center

·        Antibiotic Surveillance Committee, Maimonides Medical Center

·        Curriculum Committee Doctor of Pharmacy program, Long Island University

·        Admission Committee Doctor of Pharmacy program, Long Island University

·        ACPE Accreditation Committee College of Pharmacy and AHS, Long Island University

 

  1993 – 1995

Director of Specialized Pharmacy (Residency Program in Critical Care)

  Long Island University , Maimonides Medical Center

Brooklyn/ New York – USA

 

  1993 – 1995

Assistant Professor of Clinical Pharmacy

Long Island University

Brooklyn/ New York – USA

 

  1993– 1995

Coordinator of Critical Care Pharmacy

Maimonides Medical Center

Brooklyn/ New York – USA

 

  1991– 1993

Adjunct Assistant Professor of Medicine

Baylor College of Medicine; Department of Internal Medicine

                                                     Houston/Texas – USA          

 

1991– 1993

Hospital Pharmacist

Bay shore Medical Center

Pasadena /Texas – USA

 

Clinical Activities

   1. Medicine
         1. Daily patient rounds
         2. Acquisition of patients’ history
         3. Physical assessment
         4. Drug selection and monitoring
         5. Discharging patients
         6. Counseling
   2. Critical Care Medicine
         1. Surgical Intensive Care Unit
         2. Medical Intensive Care Unit
         3. Coronary Care Unit

(Active participation in daily patient rounds, drug therapy monitoring, providing drug information for medical residents, medical students, and nurses and also providing pharmacokinetic consultations)

 

   3. Pharmacokinetics

(The individual, kinetic study of aminoglycosides, vancomycin, theophylline and digoxin in human subjects)

   4. Psychiatry

(Reviewing patient charts for drug responses, providing past and current medication lists regarding drug effectiveness, provide drug information to medical and nursing staff and offering pharmacokinetic consultations)

   5. Emergency Medicine

(Drug therapy selection, obtaining medication history, responding to Cardio-pulmonary arrests, involvement with resuscitation of patients with drug overdoses, performing physical examinations, offering patient consultations on appropriate drug use and providing drug information to medical residents and students)

   6. Drug Information Center

(Drug utilization and evaluation review, reporting adverse drug reactions, literature search and providing drug information to medical staff)

 

Teaching Service

 

1995 - Present

Tehran University of Medical sciences

Tehran – Iran

     Coordinator of

o       Advanced Critical Care Pharmacotherapy (3 Credits),  Residency. Program in Pharmacotherapy

o       Advanced pharmacokinetics (3 Credits), Ph.D. Program in Pharmacotherapy

o       Critical Care Medicine Rotation (For Anesthesiology Resident and Fellows in Critical Cane Medicine).

o       Clinical Pharmacy Rotation (For Pharm. D Students and Pharmacy Residents)

 

Thesis:            
 

   1. Arash Jafarieh, The effect of metformin on stress induced hyperglycemia during insulin infusion, Specialty course of “Anesthesiology”, 2008 (Advisor)

   2. Fatemeh Izadpanah, The effect of pentoxifylline infusion on oxidative stress before urological surgery, Specialty course of “Clinical Pharmacy”, 2008 (Advisor)

   3. Sadegh Soltan Sharifi. Evaluation of the effect of n-acetyl cysteine following ALI/ARDS, Pharmacy, 200harmacokinetic study of aminophylline, following positive ventilation. esis 1998) (Advisor)

   4. Elham Hadidi, The plasma concentration of IL-8, TGF-alpha following brain injury, Specialty course of “Clinical Pharmacy”, 2003harmacokinetic study of aminophylline, following positive ventilation. esis 1998)(Advisor)

   5. Mohammad Rafati, Pharmacokinetic study of bolus vs. continuous infusion of  piperacillin following sepsis, Specialty course of “Clinical Pharmacy”, 2003harmacokinetic study of aminophylline, following positive ventilation. esis 1998)  (Consultant)

  6. Yunes Panahi, Evaluation of the effect of gama-interferon, following mustard gas pulmonary fibrosis, Specialty course of “Clinical Pharmacy”, 2003harmacokinetic study of aminophylline, following positive ventilation. esis 1998)  (Advisor)

  7. Farshad Hashemian, Comparison of analgesic effect of Tramadol vs. Petedine following, Specialty course of “Clinical Pharmacy”, 2000 (Advisor) harmacokinetic study of aminophylline, following positive ventilation. esis 1998)

  8. Mansoor Rastegarpanah, To design an intragastric Ph probe catheter in ICU Patients, Specialty course of “Clinical Pharmacy”, 1999 (Advisor)

  9. Mohammad R. Samadiani, Pharmacokinetic behavior of phenytoin following positive ventilation in ALI/ARDS, Specialty course of “Anesthesiology”, 1999 (Advisor)

  10. Reza, Shariat-Moharrehi, Pharmacokinetic study of aminophylline, following positive ventilation, Specialty course of “Anesthesiology”, 1999harmacokinetic study of aminophylline, following positive ventilation. esis 1998)(Advisor)

  11. Hossein Khalili, The incidence of trace element deficiencies following sepsis, Specialty course of “Clinical Pharmacy”, 1999 (Advisor) harmacokinetic study of aminophylline, following positive ventilation. esis 1998)

  12. Mollok Hajbabai, Pharmacokinetic study of aminophylline following cimetidine infusion, Specialty course of “Clinical Pharmacy”, 1999 harmacokinetic study of aminophylline, following positive ventilation. esis 1998)(Advisor)

  13. Mohamad Saffari, Comparison of bolus vs. continuous in fusion furosemide following ALI/ARDS, Specialty course of “Anesthesiology”, 1999harmacokinetic study of aminophylline, following positive ventilation. esis 1998)(Advisor)

  14. Sharam Aila, Pharmacokinetic evaluation of lidocaine via endotracheal intubation post arrest, Specialty course of “Clinical Pharmacy”, 1999harmacokinetic study of aminophylline, following positive ventilation. esis 1998)(Advisor)

  15. Ali. M. Sabzghabaie, Amikacin Pharmacokinetic behavior following sepsis, Specialty course of “Clinical Pharmacy”, 1998 (Advisor)

  16. Majid Shohrati, Phenytoin pharmacokinetic following head injury, Specialty course of “Clinical. Pharmacy”, 1998 (Advisor)

  17. Maryam Asadi, Magnesium Loading test for determination of Mg++ concentration, Specialty course of “Internal Medicine”, 1998 (Advisor)

  18. Shohreh Spltani, The effect of I.V nitroglycerin infusion on a PTT following heparin infusion, Pharmacy, 1997 (Advisor)

  19. Mojghan Salavati, The trend of drug therapy following in-hospital cardiac arrest and related mortality. Pharmacy, 1996

  20. Maryam Dayani, The appropriateness of acid suppressing agent utilization in ICU patients, Pharmacy, 1996 (Advisor)

 

Research Interests:

 
·        Pharmacokinetics and pharmacodynamics of cardiovascular agents

·        Antimicrobial agents and H2 blockers in critically ill patients

·        Pharmacotherapy of Shock, ARDS and MODS

·        Pharmacokinetic behavior  of drugs following Mechanical Ventilation

·        Organ- Organ Interaction in Critical Inness- and sepsis

 

Research Projects:
 

Ongoing

·        Design of intragastric Ph probe catheter equipped with temperature sensor (Fellowship project)

·        Anti-inflammatory effect of pantoprazole bolus doses vs. continous infusion in ICU patients (Fellowship project)

·        Evaluation of the possible anti-inflammatory effect of new remedy (IMOD) Following sepsis (Fellowship project)

·        The effect of high dose erythrocyte stimulating agent following trauma on inflammatiory cascade of SIRS (Fellowship project)

·        Comparison of EN vs. TPN on oxidative stress and cytokine outflow following sepsis (Fellowship project)

·        The effect of new iron chelating agent on inflammatory cascade following SIRS in ICU patients (Fellowship project)

·        The effect of Therapeutic Plasma exchange on inflammatory mediators following sepsis, (Fellowship project)

 

Completed

·        High dose Gentamicin dosing in ICU

·        Heparin Pharmacokinetic: Pre and Post TNG Infusion in CCU

·        Fate of Phenytoin Infusion Post Head injury

·        GSH: GST Plasma Concentrations, an indicator of MOF

·        Nitric Oxide Synthetase Inhibitors in Septic Shocks

·        Pharmacokinetic and Pharmacodynamic behavior of Ranitidin & Cimetidine infusion in critically ill patients

·        Evaluation of the appropriateness of antimicrobial agents’ use in critically ill patients

·        Lidocaine pharmacokinetic after edo –trocheal route administration post-arrest

 

Publications:

 ·        Articles

1.     Hamishehkar H., Beigmohammadi M.T., Abdollahi m, Mojtahedzadeh M. Identification of enhanced eytokine generation following sepsis., DARU, 18(3):155-162, 2010.

2.    Abrishami R, Ahmadi A, Abdollahi M, Mojtahedzadeh M, Comparison the inflammatory effects of early supplemental parenteral nutrition plus enteral nutrition alone in eritically ill patients., DARU, 18(2):103-106, 2010.

3.    Mousavi S, Mojtahedzadeh M, Abdullahi M, Place of Iron chelators like deferasirox in management of hyperoxia-induced lung injury; A systematic review Inter J of pharmaco, 6(4), 326-327, 2010

4.    Mahmoodpoor A, Eslami K, Mojtahedzadeh M, Najafi A, Ahmadi A, Examination of setarud (IMOD) in severe sepsis., DARU, 18(1), 23-28, 2010,.

5.    Moharari RS, Khajavi MR, Panahkhahi M, Mojtahedzadeh M, Najafi A., Loss of consciousness secondary to lead poisoning--case reports., Middle East J Anesthesiol. 2009 Oct;20(3):453-5.

6.    Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, Hajibabayee M, Ghahremani MH., The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine., Respir Med. 2009 Mar;103(3):434-41. Epub 2008 Nov 7.

7.    Izadpanah F, Mojtahedzadeh M, Kazem Aghamir SM, Atharikia D, Dashti S, Abbasi A., Effect of intravenous pentoxifylline in inflammatory response in patients undergoing nephrolithotomy., J Endourol. 2009 Feb;23(2):323-8

8.    Aghamir SM, Mojtahedzadeh M, Meysamie A, Atharikia D, Izadpanah F, Sheikhvatan M., Comparison of systemic stress responses between percutaneous nephrolithotomy (PCNL) and open nephrolithotomy., J Endourol. 2008 Nov;22(11):2495-500.

9.   Aghamir S, Mojtahedzadeh M. The effect of pentoxifylline on inflammatory mediators, following nephrolithotomy. Endourology. 2008. (In press)

10.    Ansari G, Mojtahedzadeh M, Kajbaf F, Nagafi A, et al. How does blood glucose control with metformin influence intensive insuliu protocols Fvidence for involrement of oxidative stress and inflammatory cytokines. Adv ther. 2008 (Pub Med – in process)

11.   Mojtahedzadeh M, Izadpanah F, Aghamir S.M'et al. Effect of intravenous pentoxifylline on oxidative stress in patients undergoing nephrolithotomy. Minervo Urologica. 2008 (In press)

12.  Mojtahedzadeh M, Panahi Y, Fazeli MR, et al. Noscomial infection in Critically Ill Patient, Receiving Stress ulcer Prophylactic Drugs. Iranian J of Pharmaceutical sciences. 2008 (In Press)

13.  Mojtahedzadeh M, Rouini M. R, Khajavi R, et al. Advantage of adjunct metformin and insulin therapy in the management of glycemia in critically ill patients. Evidence for nonoccurrence of lactic acidosis and needing to parenteral metformin. Arch Med Sci 2008; 21, 2: 174-181.

14.  Mojtahedzadeh M, Panahi Y, Fazeli MR, et al. Intensive care unit-acquired urinary tract infections in patients admitted with sepsis. Int J Infect Dis. 2008, 12 (3): 312-8.

15. Soltan. Sharifi MS, Mojtahedzadeh M, Najafi A, et al. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intra cellular glutathione …, Hum Exp Tox. 2007; 26(9): 697-703.

16.  Shohrati M. Rouini M. R, Mojtahedzadeh M. Evaluation of Phenytoin pharmacokinetics in neurotrauma patienets. Daru, 2007, 15 (1): 34-40.

17.  Kajbaf f, Mojtahedzadeh M et al. Mechanisms. Underlying Stress-induced Hyperglycemia in Critically Ill Patients. Therapy 4 (1), 97-106. 2007.

18.  Hadidi. E, Mojtahedzadeh M, et. al. Alterations of Blood IL-B, TGF-beta 1 and NO…. Therapy 3 (3). 399-405. 2006

19.  Aghamir S.K., Mojtahedzadeh M, et al. Propacetamol Vs. Tramadol for Post Operative Pain. Internet Journal of pharmacology. 4 (2) 2006.

20.  Ghanei M, Panahi Y, Mojtahedzadeh M, Effect of Gamma Interferon on Lung Function of Mustard Gas Exposed Patients, after 15 years. Pulmonary Pharmacology & Therapeutics. 7(10), 2-11, 2005

21.  Panahi Y, Mojtahedzadeh, M, The Therapeutic Effect of Gamma Interferon in Chronic Bronchitis Due to Mustard Gas. Iranian J of Allergy, Asthma and (IJAAI) 4 (2), 83-40, 2005

22.  Salari P, Mojtahedzadeh M, Comparison of the Effect of Aminophylline on Low Peep vs. High Peep on EGF Concentration in Critically Ill Patients with ALI/ARDS. Clinical pharmacy and Therapeutics (2005); 30: 139-144

23.  Salari P, Mojtahedzadeh M, Influence of Serum EGF on Mechanical Ventilation and Survival in Patients with ARDS. Therapy (2005), 2(3); 393-398

24.  Hadid E, Mojtahedzadeh M, The Evaluation of the Effect of PEEP on Pharmacokinetic of Phenytoin in Patients With ALI Under Mechanical Ventilation. DARU, 13 (2) 74-81. 2005

25.  Najafi A, Gaffer S.R, Mojtahedzadeh M, Comparison of the Incidence of Aspiration Pneumonia in Critically Ill Patients Receiving Sacral Fate or Ranitidine. Journal of Iranian Society of Anesthesiology and Intensive Care. 26 (48), 29-34.2005

26.  Vasin A, Mojtahedzadeh M, et al., Future Drugs for Treatment of Acute Respirutory Distress Syndrome. International Journal of Pharmacology 1 (1): 9-16. 2005.

27.  Mojtahedzadeh M, Vazin A, The Effect of Furosemide Infusion on Serum Epidermal Growth Factor Concentration After Acute Lung Injury. Journal of Infusion Nursing. 1 (3): 249-253, 2005

28.  Vazin A, Mojtahedzadeh M, et al., Relationship between Duration, Fatality Rate and Severity of Disease and Serum Epidermal Growth Factor in Human Acute Lung Injury. Therapy. 2 (2), 255-259, 2005

29.  Moharreri R. S, Ghazisaidi K, Mojtahedzadeh M, Purple Toes syndrome Related to Warfarin. The Internet Journal of Anesthesiology, 9 (5) 1-5, 2005

30.  Najafi A, Samdani M, Mojtahedzadeh M, Pharmacokinetic Behavior of Phenytoin Following PEEP in TBI. The Journal of Faculty of Medicine at TUMS. 62 (12), 162-167. 2005

31.  Rouini MR, Ala S, Mojtahedzadeh M, Pharmacokinetic of IV Lidocaine Infusion in Post AMI. The Journal of Faculty of Medicine. At TUMS. 62 (9), 115-120, 2005

32.  Mojtahedzadeh M, Yoosefshahi F, et al; The Efficacy of Environmental and Ventilator Tube. Disinfection by H2O2 and Silver Compounds. Journal of Iranian society of Anesthesiology and Intensive Care. 47 (3), 55-60, 2005

33.  Panahi Y, Ghaneae M, Mojtahedzadeh M, The Effect of I.V Corticosteroid on the Chemical Warfare Victims Suffering form COPD. Journal of Army University of Medical sciences of the I.R. Iran. 2 (3), 80-86, 2004

34.  Panahi Y, Ghaneae M, Mojtahedzadeh M, Evaluation of Microbial Resistance to Antibiotics in Patients With COPD due to…… Journal of Military Medicine. 6 (3), 25-31, 2004

35.  Sohrevardi S.M, Mojtahedzadeh M, et al; Role of Magnesium Loading Test in Detecting Hypomagnesemia in Critically Ill Patients. MJIR. Iran 18 (1), 35-42, 2004

36.  Mojtahedzadeh M, Hashemian F, et al; Comparison of the Analgesic Profile and Side Effects of Tramadol VS Pethidine………… DARU, 12 (3), 111-114, 2004

37.  Mojtahedzadeh M, Ala S, A study of Lidocaine Pharmacokinetic Behavior Following Endotracheal Administration in ICU. Journal of Medical Faculty Guilan University of Medical Sciences. 13 (49), 9-14, 2004

38.  Mojtahedzadeh M, Phrmacokinetic Behavior of Theophylline Following PEEP in Critically Ill Patients. IJPR, 2004, 3: 35 - 40

39.  Mojtahedzadeh M, Comparison of Hemodynamic and Biochemical Effects of Furosemide by Continuous Infusion and Bolus in ICU. JIN 2004, 27: 255 – 261

40.  Mojtahedzadeh M, The value of Aminophylline Dosing Based on Pharmacokinetic Variables in Critically Ill Patients. Journal of Medical council IR. IRAN , 2004, 22: 28 – 31

41.  Mojtahedzadeh M, Pharmacokinetic Behavior of Phenytoin following Positive end Expiratory Pressure in Traumatic Brain Injury Patients with Acute Lung Injury. Journal of lranian society Anaesthesiology 2004, 24: 6 – 15

42.  Mojtahedzadeh M, The Effect of Positive End Expiratory Pressure on Pharmacokinetic Behavior of Aminophylline in ALI. Journal of lranian society of Anaesthesiology 2004, 24: 26 - 33

43.  Mojtahedzadeh M, Sadray S, et al; Determination of Theophylline Clearance after Cimetidine Infusion in Critically Ill Patients. JIN. 2003; 26: 234-238

44.  Mojtahedzadeh M, Khalili H, et. al., Quality of Nutrition in Critically Ill Patients. Biomed Research. 2003; 14(1): 161-165

45.  Ghanei M, Panahi Y, Mojtahedzadeh M, Succesful Treatment of Pulmonary Obstructiive Lesion in Chemical Warfare Casulties With Gamma – Interferon. Kowsar Medical Journal. 2003; 8: 151 – 157 

46.  Soroosh A.R, Mojtahedzadeh M, Comparatire Disease Assessment of Tramaldol versus Morphine for Post Operative Pain Relief. The Journal of faculty of Med at TUMS. 2003; 6: 67-73

47.  Behrad V, Mojtahedzadeh M, et. al.: A Prospective Randomized Controlled Trial of High and Low Doses of Magnesium Sulfate for Acute Tocolysis. Acta Medica Iranica. 2003; 41: 126- 131

48.  Mojtahedzadeh M, Rastegarpanah M, et. al.: A Comparative study of Bolus Administration and Continuous Infusion of Ranitidine on Gastric pH in ICU. DARU. 2003; 10: 153-157 

49.  Mojtahedzadeh M, et al: Correlation of Free Fraction of Phenytoin and Plasma Albumin Level in Head Trauma. DARU 10: 1. 2002 P 1-5

50.  Mojtahedzadeh M, et al: Amikacin Pharmacokinetics Behavior in Iranian Critically Ill Septic Patients. DARU. 2002; 10;111-119

51.  Mojtahedzadeh M, et al: Gastric PH, Concentrations of Ranitidine in Gastric Juice and Plasma in Critically Ill Patients Pharm. Pharmacol 2000 –60: 135-140

52.  Mojtahedzadeh M, et al: Pharmacotherapy of Cardiae Arrest For Children, TEB; TAZKIEH 2000; 36; 68-85

53.  Mojtahedzadeh M. et al: A Prospectiveevaluations of Amiodaron and Magnesium Sulfate Infusion for Supraventricular Tachyarrhythmia in Critically Ill Patients. DARU 1999,7; 3, 10-17

54.  Mojtahedzadeh M, et al: A Point of view for Phyridistigmine Infusion in Management of Myasthenic Crisis. Acta Medical Iranica 1998 ; 36 ;2,122-124

55.  Mojtahedzadeh M, et al: Use of Flumazenil to Provide Adequate Recovery Time Post – Midazolam Infusion. DARU 1998 7 ; 2 PP 25-28

56.  Mojtahedzadeh M, et al: Multi Drug Resistance during Treatment of Mycobacterium TB in ICU. Razie,1998, 1, 9, PP 86- 94

57.  Mojtahedzadeh M, Acute Renal Failure in Critically Ill Patients. RAZIE , 199; 9,36-

58.  Mojtahedzadeh M, et al: Torsade de Pointes Induced by Terfenadine – Erythromycin Drug Interaction Serious Arrhythmia Causing Death MJIRI, 1998, 12 : 3 PP 299-301

59.  Mojtahedzadeh M, Pharmacological  Considerations in Acute Care Medicine Razie 1997, 4: 8,PP 51-58

60.  Mojtahedzadeh M, Rastegar M, Upper Gastric Erosions in ICU Razie, 1996, 7: 1101 – 1108

61.  Mojtahedzadeh M, Baghaie A, Levine R, et al. Comparison of the Effect of Continuous Infusion versus Intermittent Administration of Famotidine on Gastric PH in Critically Ill Patients, Critical care Med 1995, 47: 1910- 1915

62.  Mojtahedzadeh M, Levine R, Fromm R, Baghaie a, et al. The Equivalence of Litmus Paper and Intragastric PH Probes for Intragastric PH Monitoring in the ICU. Critical Care Medicine 1993; 22: 945 – 948

63.  Mojtahedzadeh M, Baghaie A, Guidelines for Obtaining Plasma Drug Concentrations Microgram Newsletter. 1992, 9: 4-7

 

·        Printed Abstracts

1.   M. Mojtahedzadeh. Aminophylline in the Treatment of Brady – Asystol Irainan Heart Journal, Oct 8- 11 –2002 Tehran P 289-291

2.   M. Mojtahedzadeh. Quality Assessment of Infections Control Measures among 21 ICUs in Tehran , International Congress of Anesthesiology. Oct. 2002 Shiraz . P. 126

3.   M. Mojtahedzadeh. Comparison of the Effect of Tramadol vs. Morphine in Pain Control following Surgery. International Congress of Anesthesiology. Oct. 2002. Shiraz p. 136

4.   Mojtahedzadeh M. et al: Pharmacokintic Behavior of Once a Day Dosing of Gentamicine (3 mg/kg) in Critically Ill Patients. 14 th. Iranian Congress of Physiology and Pharmacology, 1999, L 77, P 164

5.   Mojtahedzadeh M. et al: Comparison of the Equivalence of Efficacy Ranitidine Infusion Made Locally with Zantac ( Glaxo, Inc ) in Critically Ill Patients. 14th. Iranian Congress of Physiology and Pharmacology – 1999, L 284 , P 193

6.   Mojtahedzadeh M. et al: To determine Outcomes after Cardiopulmonary Resuscitation in Adult Cardiac Arrest Patients. 14 TH Iranian Congress of Physiology and Pharmacology.1999, P 296, P 199

7.   Mojtahedzadeh M. et al: Intragasteric pH Monitoring and Bacterial Colonization in Critically Ill Patients. 10 th. Congress of Iranian College of Internal Medicine. P 225.

8.   Mojtahedzadeh M. et al: Comparing a Computerized Method ( Datakinetic ) and Sawchuk and Aske in Dosing Critically Ill Patients Receiving Gentamicin. The Fifth Iranian Conference of Pharmaceutical Sciences, 1997, 245

9.   Mojtahedzadeh M. Yousefian S. Rastegar M. Nitroglycerin and Heparin Drug Interactions in Cardiac Surgical Patients. International Conference in Clinical Cardiology. Tehran , 1996

10.  Mojtahedzadeh M. Baghaie a, Levine r. et al. A comparison of Continuous Infusion versus Intermittent Administration of Ranitidinin Critically Ill Patients. Society of Critical Care Medicine, New York 1993

11.  Mojtahedzadeh M. Baghaie a, Levine r. et al. Comparison of Continuous Infusion versus Intermittent Administration of Ranitidine in Critically Ill Patients. Society of Critical Care Medicine, New York 1993

12.   Edokpa A, Baghaie A, Mojtahedzadeh M. Relative Performance of Womicrocomputer – based Pharmacokinetic Monitoring Programs in Predicting Vancomycin Serum Concentrations. ASHP Mid – Year Clinical Meeting,Orlando 1992

13.  Hackett – Belford K, Baghaie A, Levine Mojtahedzadeh M. Pharmacokinetic Behavior of Vancomycin in Critically Ill Edical Intensive Care Patients. ASHP Mid- Year Clinical Meeting, Las Vegas , 1990\

 

·        Presentations

1.   1997 – Present: Over 1/000 presentations on areas of Pharmacotherapy and Critical Care Medicine

2.    April 1996: New Horizons in Pharmacy Practice, Tehran University , Continued Education Program for Pharmacists and Physicians

3.    July 1996: To Predict or to Create, Tehran University

4.    August 1996: Logics of Fluid Therapy in Critically Ill Patients, Alzahra General Hospital

5.    September 1996: Role of Nitric Oxide in Pathogenesis of Septic Shock. Internal Medicine Grand Round

6.    December 1993: How to Interpret Medical Journals, Maimonides Medical Center, Residents Grand Rounds,sponsored by Glaxo, Brooklyn, New York.

7.     November 1993: Pharmacological Alternatives to Sodium Bicarbonate in Treatment of Aniongap Metabolic Acidosiss, Maimonides Medical Center, Residents Grand Rounds, Sponsored by Merck, Brooklyn, New York

8.     October 1992: Pharmacokintics of Ammoglycosides and Vancomyccin in Critically Ill Patients, To the Pharmacy Staff of the Methodist Hospital Houston , Texas

9.     September 1992: A new Benzodiazepine Antagonist. To the emergency room physicians and nurses, the Methodist Hospital , Houston , Texas

10.  August 1992: Antioxidants in the Management of Phypercholesterolemia. To pharmacists and nurses at Continued Education Program (CE), titled the Role of Antihyperlipidemic Agents in the Management of Hypercholesterolemia, sponsored by Glaxo Company, Houston , Texas

11.  July 1992: Beta – Blocker Use and Myocardial Events. To pharmacists and nurses at Continued Education program (CE) titled the Use of Beta – Blocker in Selected Cardiovascular Disorders, Sponsored by Glaxo Company, Houston , Texas

12.  May 1992: A Comparison of Continuous Infusion Versus Intermittent Administration of Famotidine on Gastric PH in Critically Ill Patients. To pharmacists, College of Pharmacy Faculty , Pharmacy Students at Texas Southern University, Houston , Texas

13.   April 1992: Stress-related Mucosal Infury in Critically Ill Patients. To  pharmacists, nurses and pharmacy students at Continued Education program (CE) titled Pharmacotherapy in Critically Ill Patients,  Sponsored by Glaxo, Houston , Texas

14.   February 1992: Sepsis Sydrome in Critically Ill Patients, To pharmacists, students and pharmacy staff at the College of Pharmacy , Texas Southern University

15.  November 1991: Hyponatremia in HIV Positive IV Drug Abused, To Pharm. D. students and pharmacy staff  at the college of Pharmacy , Texas Southern University

16.  October 1991: Critical Care Considerations of Victims Post-exposure to Nerve Agents, to Pharm. D. students and pharmacy staff at the college of Pharmacy , Texas Southern University

17.  September 1991: The Role of Anitibiotic Monotherapy in Treatment of Serious Surgical Infections, to Pharm. D. students and pharmacy staff at the College of Pharmacy , Texas Southern University

18.  June 1991: Electroconvulsive Therapy, a Safe and Effective Alternative Treatment of Affective Disorders, To Pharm. D. Students and pharmacy staff at the College of Pharmacy , Texas Southern University

 

Grants:


Completed Grants

·   A randomized, open label clinical study of Tramadol Vs. Morphine with regard to respiratory function and pain relief following surgery, Funded by Grunenthal Germany

·   Furosemide Pharmacokinetic in critically ill patients, TUMS Pharmaceutical Research Center

·   Development of National Poison and Drug Information Center , Funded by the Ministry of Health and Medical Education.

·   Specialized Pharmacy Residency Program in Critical Care Medicine at long Island University , Funded by Schwartz Foundation.

·  The comparison of continuous infusion Vs. intermittent administration of famotidine in critically ill patients, Funded by Merck Pharmaceutical.

·   Hemodynamic effects of farmotidine infusion in critically ill patients, American Heart Association, New York affiliate.

 

Pending Grants

·        Vitamin E disposition Following ARDS in critically ill mechanically ventilated patients. Funded by TUMS.

·        Metformin Following stress intuced hyperglycemia, funded by pharmaceutical research center of TUMS.

·        Design; Development of Intragastric Ph. Probe catheter, with temperature sensor. Funded by Exir pharmaceutical, Kobel Compary; TUMS.

·        New Remedie (IMOD) for sepsis treatment. Funded by Medicinal plant research center

·        The effect of low dose dopamine on renal function in critically ill patients with renal dysfunction (Funding is pending)

 

Awards:                                

2005                Sina excellence in education award (TUMS)

1998                Sina excellence in education award (TUMS)

1997                Sina excellence in education award (TUMS)

1992                 The Excellence in Clinical Pharmacy Awards, Presented by Hoechst-Roussel Pharmaceuticals Inc.

1992                 The Upjohn Excellence Award in Pharmacy Research, Presented by Upjohn Pharmaceuticals

Competencies:


·        Language

o       Fluent in English

 
·        Computer

o       LANS

o       Fortran




Comments :

Time & Date: 10:50- 1398/5/31
Name :
E-Mail :
HomePage :
Your Message :
Doctors Search
Find :    
      
Users Panel


Username :

Password :